Are lipid-lowering guidelines evidence-based?

Lancet. 2007 Jan 20;369(9557):168-9. doi: 10.1016/S0140-6736(07)60084-1.

Authors

J Abramson¹, J M Wright

Affiliation

¹ Harvard Medical School, Cambridge, Massachusetts, USA.

PMID: 17240267
DOI: 10.1016/S0140-6736(07)60084-1

No abstract available

MeSH terms

Adult
Aged
Coronary Disease / prevention & control*
Evidence-Based Medicine / statistics & numerical data*
Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Male
Middle Aged
Primary Prevention / statistics & numerical data*
Randomized Controlled Trials as Topic
Treatment Outcome

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors